VORNvc

VORN is a biotechnology company based in Basel, Switzerland, focused on developing a novel class of RNA-based medicines using extracellular vesicles (EVs) as a delivery vehicle. The company's proprietary platform leverages the natural ability of EVs to transport complex molecular cargo, such as mRNA and other RNA modalities, directly to target cells with high specificity and low immunogenicity. By overcoming the traditional limitations of lipid nanoparticles and viral vectors, VORN aims to expand the therapeutic reach of RNA therapies into previously inaccessible tissues and organs. The company is currently in the pre-clinical stage, advancing its internal pipeline while exploring strategic partnerships to validate its delivery technology across multiple disease areas.